Author

J. Bussink

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

C. Frielink· 1 shared D. F. Boreel· 1 shared D. Kroon· 1 shared E. Oosterwijk· 1 shared G. Franssen· 1 shared G. Tamborino· 1 shared J. Hillen· 1 shared J. Molkenboer-Kuenen· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

C. Frielink

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Towards Effective CAIX-targeted Radionuclide and Checkpoint Inhibition Combination Therapy for Advanced Clear Cell Renal Cell Carcinoma

S. C. Kleinendorst, E. Oosterwijk, J. Molkenboer-Kuenen, C. Frielink, G. Franssen, D. F. Boreel, G. Tamborino, M. Gloudemans, M. Hendrikx, D. Kroon, J. Hillen, J. Bussink, S. Muselaers, P. Mulders, M. W. Konijnenberg, , S. Heskamp

This study investigates the combination of targeted radionuclide therapy and immune checkpoint inhibitors for advanced clear cell renal cell carcinoma, showing enhanced therapeutic outcomes and immune microenvironment changes.

bioRxiv · Feb 16, 2024Cancer Biology